Oral Solid Dosage Pharmaceutical Formulation Market Value to Reach US$ 926.3 Billion by 2027 End


Posted December 15, 2017 by hawerr

Oral Solid Dosage Pharmaceutical Formulation Market: Emerging Markets of Latin America, APEJ and MEA to Collectively Hold over 45% Market Value Share

 
Future Market Insights (FMI), in its report, projects the global oral solid dosage pharmaceutical formulation market to register 6.5% CAGR during the forecast period 2017 to 2027. In terms of revenue, the market will reach nearly US$ 500,000 Mn in 2017; by 2027 is further estimated to surpass US$ 900,000 Mn.

Report overview@ https://www.futuremarketinsights.com/reports/oral-solid-dosage-pharmaceutical-formulation-market

Based on release mechanism, immediate release will remain dominant in the market, expanding at 6.4% CAGR through 2027. Immediate release is expected to generate revenue over US$ 400,000 Mn by 2027-end. Controlled release under extended release segment, is expected to register 7.4% CAGR through 2027.

Retail pharmacy is expected to be the largest end-user of oral solid dosage pharmaceutical formulation market by 2027-end. Retail pharmacy is expected to exhibit highest CAGR in the market through 2027. In contrast, Hospital pharmacy is expected to exhibit lowest CAGR, even though it stands as second largest end-user in the market during the forecast period.

North America will remain the largest market for oral solid dosage pharmaceutical formulation, followed by Asia Pacific Excluding Japan (APEJ) and Western Europe. Revenue from the market in North America is expected to surpass US$ 300,000 Mn by 2027-end. In addition, APEJ is projected to reach revenue worth US$ 294,750.4 Mn in the market by 2027. Latin America is expected to be the fastest growth region in the market, expanding at 9.2% CAGR through 2027. In contrast, Japan will witness a sluggish growth in the market.

Request to sample report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2782

By dosage form, tablets will continue to remain preferred in the market, with sales estimated to surpass US$ 500,000 Mn by 2027-end. Sales of tablets are anticipated to exhibit the highest CAGR in the market, followed by capsules. Capsules are expected to be the second most lucrative dosage form in the market, expanding at 6.1% CAGR through 2027.

Summary of Table of Content

1.Executive Summary
2.Market Introduction
3.Oral Solid Dosage Pharmaceuticals Market View Point
4.North America Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027
5.Western Europe Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027
6.Eastern Europe Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027
7.Latin America Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027
8.Asia Pacific Excluding Japan Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027
9.Japan Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027
10. Middle East and Africa Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
14. Global Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027 By Region
15. Global Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027, By Dosage Form
16. Global Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027, By Drug Release Mechanism
17. Global Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel
18. Global Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027
19. Assumptions and Acronyms Used
20. Research Methodology

Request to Browse Full Table of Content, figure and Tables@ https://www.futuremarketinsights.com/toc/rep-gb-2782

ABOUT US:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: [email protected]
Website: www.futuremarketinsights.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Future Market Insights
Country United States
Categories Health , Medical , News
Tags oral solid dosage pharmaceutical formulation market
Last Updated December 15, 2017